COMPASS Pathways (CMPS) granted two US patents

Go back to COMPASS Pathways (CMPS) granted two US patents

COMPASS Pathways granted two US patents

March 23, 2021 8:00 AM EDT

COMPASS Pathways granted two US patents

London, UK 23 March 2021     COMPASS Pathways plc (Nasdaq: CMPS) (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it has been granted two new patents by the US Patent and Trademark Office (USPTO). These patents cover oral formulations of COMPASSs synthetic psilocybin in the treatment of major depressive disorder (MDD), which includes... More